NCT00215436已完成3 期
A 12-week Double-Blind, Parallel-Group, Placebo- and Active- Controlled Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate Inhalation Solution 20 Mcg in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
Dey45 个研究点 分布在 1 个国家目标入组 345 人开始时间: 2005年3月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 345
- 试验地点
- 45
- 主要终点
- Measure of lung function
研究概览
简要总结
The purpose of this study is to determine the safety and efficacy of the investigational drug in comparison with a placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Medical diagnosis of COPD
- •Current or prior history of cigarette smoking
排除标准
- •Medical diagnosis of asthma
- •Chest X-ray diagnostic of significant disease other than COPD
- •Significant condition or disease other than COPD
结局指标
主要结局
Measure of lung function
次要结局
- Change in lung function, as well as vital signs
- Physical Exam results, Adverse event reporting, etc
研究者
研究点 (45)
Loading locations...
相似试验
已完成
3 期
A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPDCOPDNCT00280371Dey345
已完成
2 期
Double-blind, Randomised, Placebo-controlled Trial Investigating BIRT 2584 XX in Patients With Moderate/Severe PsoriasisPsoriasisNCT00333411Boehringer Ingelheim360
已完成
2 期
A Study of Enzalutamide and LY3023414 in Men With Prostate CancerProstate Cancer MetastaticNCT02407054Eli Lilly and Company142
已完成
2 期
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque PsoriasisPlaque PsoriasisNCT01483924ApoPharma60
已完成
2 期
A Study to Evaluate the Clinical Efficacy, Safety and Tolerability of ARX-F03 Sublingual Sufentanil/Triazolam NanoTab™ in Patients Undergoing an Elective Abdominal Liposuction ProcedureSedationPainAnxietyNCT00894699Talphera, Inc40